Cellyan Biotechnology received a Nasdaq Listing Qualification Department notification on July 14, 2026 granting additional time to regain compliance with the exchange’s minimum bid price requirement. While this provides runway versus an outright delisting risk, the company remains under bid-price compliance pressure.
Cellyan Biotechnology received a Nasdaq Listing Qualification Department notification on July 14, 2026 granting additional time to regain compliance with the exchange’s minimum bid price requirement. While this provides runway versus an outright delisting risk, the company remains under bid-price compliance pressure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.22
Ticker Sentiment
